Navigation Links
Ceres and Syngenta to Collaborate on Sweet Sorghum Market Development
Date:11/26/2012

operations throughout the season.  The cultivation of sweet sorghum enables growers to use land and water resources more efficiently. In collaboration with Ceres, we aim to develop this opportunity by deploying our crop protection portfolio to achieve consistent yield improvement," said Daniel Bachner, Syngenta's Global Head of Sugarcane.

ABOUT CERES  
Ceres, Inc. (www.ceres.net) is an agricultural biotechnology company that markets seeds for energy crops used in the production of renewable transportation fuels, electricity and bio-based products. The company combines advanced plant breeding and biotechnology to develop products that can address the limitations of first-generation bioenergy feedstocks, increase biomass productivity, reduce crop inputs and improve cultivation on marginal land. Its development activities include sweet sorghum, high-biomass sorghum, switchgrass and miscanthus. Ceres markets its products under its Blade brand.

ABOUT SYNGENTA   
Syngenta is one of the world's leading companies with more than 26,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com.

CERES FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements. All statements, other than statements of historical facts, including statements regarding our efforts to develop and commercialize our products, our short-term and long-term business strategies, market and industry expectations, future operating metrics, product yields and future results of operations and financial position, are forward-looking statements. You should not place undue relian
'/>"/>

SOURCE Ceres, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Ceres Receives $3.5 million from USAID for Trait Stacks
2. Ceres Expands Board of Directors with former BP Chief Scientist and Undersecretary of Energy Steven Koonin
3. Syngenta divests US flowers distribution and brokerage
4. Syngenta Secures EU Approval For Next Generation Fungicide
5. Pasteuria Bioscience to be Acquired by Syngenta
6. Syngenta to acquire Pasteuria Bioscience
7. Syngenta and Devgen enter insect control research partnership
8. GNS Healthcare, Dana-Farber and Mount Sinai Collaborate to Build Computer Model of Multiple Myeloma
9. Elsevier Collaborates With Infocomm Development Authority of Singapore and Top Academic Institutions to Bring CodeForScience to Singapore
10. ASAE, TMG Custom Media Collaborate to Launch New Print-Plus-Digital Strategy for Associations Now Magazine
11. Genetics Policy Institute (GPI) Collaborates on Second Midwest Conference on Stem Cell Biology and Therapy, Oct. 5-7 at Oakland University
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... and TORONTO , June 2, 2015 ... APS), a clinical-stage company developing new therapeutics that target ... U.S. Food and Drug Administration (FDA) has granted the ... of acute myeloid leukemia (AML). APTO-253, a first-in-class inducer ... candidate in a Phase Ib clinical trial in patients ...
(Date:6/2/2015)... Tauriga Sciences, Inc. (OTCQB:  TAUG) ("Tauriga" or ... interests in the natural wellness sector and in ... announced that it has officially extinguished all further ... for a one-time cash payment of $230,000 USD.  ... entered into a Settlement Agreement (the "Settlement Agreement") ...
(Date:6/2/2015)... June 2, 2015 Meet ARGUS, ... Scanner. Scan & Read People. Analyze emotions and predict ... Concepts, including the very first Responsive-RPG: "The Eye: Genesis". ... , , , , https://www.youtube.com/watch?v=B1ZEtAZ2Yf8 ... truly affect your inner feelings - and those of ...
(Date:6/2/2015)... 2015   Hospira, Inc. (NYSE: HSP ... its partner, Celltrion – a global biopharmaceutical company – has ... Agency in Brazil – for ... use in Brazil . The medication ... sells biosimilar infliximab in 26 European countries and in ...
Breaking Biology Technology:Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 2Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 3Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 4Tauriga Sciences, Inc. Extinguishes All Further Obligations to Typenex Co-Investment LLC with One-Time Cash Payment of $230,000 USD 2Tauriga Sciences, Inc. Extinguishes All Further Obligations to Typenex Co-Investment LLC with One-Time Cash Payment of $230,000 USD 3Tauriga Sciences, Inc. Extinguishes All Further Obligations to Typenex Co-Investment LLC with One-Time Cash Payment of $230,000 USD 4ARGUS - The World's First Inner Emotion Scanner Launches on KickStarter 2ARGUS - The World's First Inner Emotion Scanner Launches on KickStarter 3ANVISA Approves First Infliximab Biosimilar in Brazil 2ANVISA Approves First Infliximab Biosimilar in Brazil 3ANVISA Approves First Infliximab Biosimilar in Brazil 4ANVISA Approves First Infliximab Biosimilar in Brazil 5
... KANSAS CITY, Kansas , Aug. 5 Oncimmune® ... test that aids physicians in risk assessment and the early ... study that demonstrates the clinical validity of the test. The study ... Diagnosis " is now available on line at Annals of ...
... how a new type of experimental antibiotic can ... treatments [1]. The findings could ultimately help scientists ... responsible for many hospital and community-acquired infections. ... team of researchers from GlaxoSmithKline (GSK) captured a ...
... , Aug. 4 Forte, LLC, ... a web-based probate database and estate recovery application ... Probate Finder OnDemand provides access to a proprietary ... records, powerful matching algorithms that accurately match deceased ...
Cached Biology Technology:New Study Demonstrates Clinical Validity of EarlyCDT-Lung™ 2New Study Demonstrates Clinical Validity of EarlyCDT-Lung™ 3New Study Demonstrates Clinical Validity of EarlyCDT-Lung™ 4New Study Demonstrates Clinical Validity of EarlyCDT-Lung™ 5New Study Demonstrates Clinical Validity of EarlyCDT-Lung™ 6Image of new antibiotic in action opens up new opportunities to combat antibacterial resistance 2Forte Launches Probate Finder OnDemand™ 2Forte Launches Probate Finder OnDemand™ 3
(Date:4/20/2015)... PASADENA, Calif. , April 20, 2015 ... San Gabriel Valley to implant a new miniaturized, wireless ... HF System is the first and only FDA-approved heart ... reduce hospital admissions when used by physicians to manage ... a sensor that is implanted in the pulmonary artery ...
(Date:4/17/2015)... Increasing adoption in ... to drive biometric systems market in ... According to a recently released TechSci Research ... biometric systems market in Saudi Arabia ... CAGR of over 22% through 2020. The market ...
(Date:4/14/2015)... April 14, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces ... the 2015 New York Design Awards under the category  ... York City Design Awards are part of a global ... 2,500 ratings from the marketplace, industry and judging panel. ...
Breaking Biology News(10 mins):Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 2Saudi Arabia Biometric Systems Market to Grow at 22% Through 2020, Says TechSci Research 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3
... new, more effective and personalized cancer treatments, Horizon Discovery, ... Reserve University exclusive rights to a panel of new ... Zhenghe John Wang, assistant professor of genetics at the ... initially for 10 years and includes up-front fees and ...
... Institute at Virginia Tech have discovered how abscisic ... properties for the treatment of disease, helps fight ... published in the November 2010 Journal of ... for the development of treatments for inflammatory and ...
... Mich. The risk of esophageal cancer among patients ... as high as many may think, according to new ... considered a relative risk for developing esophageal adenocarcinoma, but ... M.D., M.Sc., an investigator with the Department of Veterans ...
Cached Biology News:Isogenic cell models for cancer research exclusively licensed to Horizon Discovery 2Researchers discover how natural drug fights inflammation 2Researchers discover how natural drug fights inflammation 3Esophageal cancer risk lower than expected for patients with GERD 2
A component of the Acridinium protein labeling kit....
... to human XAB2 (amino terminus) XAB2 ... its interaction with XPA. Immunoprecipitation experiments have ... interacts with the transcription-coupled repair-specific proteins CSA ... polymerase II. Microinjection experiments with XAB2 antibodies ...
...
... calibration, and validation (MCV) plate ... plate used for hands-free startup, ... using the Bio-Plex suspension array ... for use with Bio-Plex Manager ...
Biology Products: